Skip to main content

Closed

DFTX: Definium Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-60.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-13.3×

Current ratio4.69×

Definium Therapeutics, Inc.

DFTXNASDAQ Global Select·USD·Closed

Definium Therapeutics, Inc.

DFTXNASDAQ·USD·Closed

$43.52

−2.18%

$43.52

−$0.97 (2.18%)

52W Range

84thpctl

Volume

0.35×avg

Mkt Cap

4.75BUSD

P/E

-17.4TTM

Div Yield

–ann

52W Range

84thpctl

Volume

0.35×avg

Market Cap

4.75BUSD

P/E Ratio

-17.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings